Celltrion Pharm has ranked among the top searched stocks for 12 days in the past month.

As of 2:31 PM on the 12th, Celltrion Pharm is trading at 135,500 KRW, up 1.35% from the previous day. This marks a 62.08% increase compared to May 19. Celltrion Pharm is known as a company specializing in pharmaceuticals and health supplements.

Today, foreigners have net purchased 60,000 shares of Celltrion Pharm, while institutions have net sold 1,000 shares, according to provisional data. Over the past five days, individual investors have net sold 30,449 shares, while foreigners and institutions have net purchased 17,531 shares and net sold 1,280 shares, respectively.

On June 3, Celltrion Pharm became a market issue with headlines such as "Insulin injection development and consecutive days of COVID-19 treatment experiment results..."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing